Dan has spent much of his career focused on commercialization strategy for pipeline assets as well as life-cycle management. He is a truly ambidextrous market researcher, that can design complex quantitative solutions one day, and then seamlessly moderate emotional drivers research leveraging projective research techniques the next.   

A respected leader, Dan has guided his teams to plan, develop and present strategic engagements across the brand lifecycle including early opportunity assessments, clinical development strategy, new product launch planning and execution, marketing communication and in-line strategy. He has extensive global experience leading custom quantitative and qualitative engagements, including conjoint analyses, chart research, segmentation, forecasting, marketing and communication development, and pricing across the 7 major markets and beyond. 
 
Dan believes in engaging respondents and clients through the development of innovative, custom solutions that generate both rational and emotional insights leading to action.  He is an active listener, with expertise and knowledge across many therapeutic areas including rare disease, immunology, CNS disorders, oncology, renal disease, pulmonary disease, and cardiovascular disease.